Cargando…

A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD

The prognosis of patients with nonalcoholic fatty liver disease-related hepatocellular carcinoma (NAFLD-HCC) is intricately associated with various factors. We aimed to investigate the prognostic algorithm of NAFLD-HCC patients using a data-mining analysis. A total of 247 NAFLD-HCC patients diagnose...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Takumi, Tokushige, Katsutoshi, Hyogo, Hideyuki, Aikata, Hiroshi, Nakajima, Tomoaki, Ono, Masafumi, Kawanaka, Miwa, Sawada, Koji, Imajo, Kento, Honda, Koichi, Takahashi, Hirokazu, Mori, Kohjiroh, Tanaka, Saiyu, Seko, Yuya, Nozaki, Yuichi, Kamada, Yoshihiro, Fujii, Hideki, Kawaguchi, Atsushi, Takehara, Tetsuo, Yanase, Mikio, Sumida, Yoshio, Eguchi, Yuichiro, Seike, Masataka, Yoneda, Masato, Suzuki, Yasuaki, Saibara, Toshiji, Karino, Yoshiyasu, Chayama, Kazuaki, Hashimoto, Etsuko, George, Jacob, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041283/
https://www.ncbi.nlm.nih.gov/pubmed/29992975
http://dx.doi.org/10.1038/s41598-018-28650-0
_version_ 1783338960548790272
author Kawaguchi, Takumi
Tokushige, Katsutoshi
Hyogo, Hideyuki
Aikata, Hiroshi
Nakajima, Tomoaki
Ono, Masafumi
Kawanaka, Miwa
Sawada, Koji
Imajo, Kento
Honda, Koichi
Takahashi, Hirokazu
Mori, Kohjiroh
Tanaka, Saiyu
Seko, Yuya
Nozaki, Yuichi
Kamada, Yoshihiro
Fujii, Hideki
Kawaguchi, Atsushi
Takehara, Tetsuo
Yanase, Mikio
Sumida, Yoshio
Eguchi, Yuichiro
Seike, Masataka
Yoneda, Masato
Suzuki, Yasuaki
Saibara, Toshiji
Karino, Yoshiyasu
Chayama, Kazuaki
Hashimoto, Etsuko
George, Jacob
Torimura, Takuji
author_facet Kawaguchi, Takumi
Tokushige, Katsutoshi
Hyogo, Hideyuki
Aikata, Hiroshi
Nakajima, Tomoaki
Ono, Masafumi
Kawanaka, Miwa
Sawada, Koji
Imajo, Kento
Honda, Koichi
Takahashi, Hirokazu
Mori, Kohjiroh
Tanaka, Saiyu
Seko, Yuya
Nozaki, Yuichi
Kamada, Yoshihiro
Fujii, Hideki
Kawaguchi, Atsushi
Takehara, Tetsuo
Yanase, Mikio
Sumida, Yoshio
Eguchi, Yuichiro
Seike, Masataka
Yoneda, Masato
Suzuki, Yasuaki
Saibara, Toshiji
Karino, Yoshiyasu
Chayama, Kazuaki
Hashimoto, Etsuko
George, Jacob
Torimura, Takuji
author_sort Kawaguchi, Takumi
collection PubMed
description The prognosis of patients with nonalcoholic fatty liver disease-related hepatocellular carcinoma (NAFLD-HCC) is intricately associated with various factors. We aimed to investigate the prognostic algorithm of NAFLD-HCC patients using a data-mining analysis. A total of 247 NAFLD-HCC patients diagnosed from 2000 to 2014 were registered from 17 medical institutions in Japan. Of these, 136 patients remained alive (Alive group) and 111 patients had died at the censor time point (Deceased group). The random forest analysis demonstrated that treatment for HCC and the serum albumin level were the first and second distinguishing factors between the Alive and Deceased groups. A decision-tree algorithm revealed that the best profile comprised treatment with hepatectomy or radiofrequency ablation and a serum albumin level ≥3.7 g/dL (Group 1). The second-best profile comprised treatment with hepatectomy or radiofrequency ablation and serum albumin levels <3.7 g/dL (Group 2). The 5-year overall survival rate was significantly higher in the Group 1 than in the Group 2. Thus, we demonstrated that curative treatment for HCC and serum albumin level >3.7 g/dL was the best prognostic profile for NAFLD-HCC patients. This novel prognostic algorithm for patients with NAFLD-HCC could be used for clinical management.
format Online
Article
Text
id pubmed-6041283
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60412832018-07-13 A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD Kawaguchi, Takumi Tokushige, Katsutoshi Hyogo, Hideyuki Aikata, Hiroshi Nakajima, Tomoaki Ono, Masafumi Kawanaka, Miwa Sawada, Koji Imajo, Kento Honda, Koichi Takahashi, Hirokazu Mori, Kohjiroh Tanaka, Saiyu Seko, Yuya Nozaki, Yuichi Kamada, Yoshihiro Fujii, Hideki Kawaguchi, Atsushi Takehara, Tetsuo Yanase, Mikio Sumida, Yoshio Eguchi, Yuichiro Seike, Masataka Yoneda, Masato Suzuki, Yasuaki Saibara, Toshiji Karino, Yoshiyasu Chayama, Kazuaki Hashimoto, Etsuko George, Jacob Torimura, Takuji Sci Rep Article The prognosis of patients with nonalcoholic fatty liver disease-related hepatocellular carcinoma (NAFLD-HCC) is intricately associated with various factors. We aimed to investigate the prognostic algorithm of NAFLD-HCC patients using a data-mining analysis. A total of 247 NAFLD-HCC patients diagnosed from 2000 to 2014 were registered from 17 medical institutions in Japan. Of these, 136 patients remained alive (Alive group) and 111 patients had died at the censor time point (Deceased group). The random forest analysis demonstrated that treatment for HCC and the serum albumin level were the first and second distinguishing factors between the Alive and Deceased groups. A decision-tree algorithm revealed that the best profile comprised treatment with hepatectomy or radiofrequency ablation and a serum albumin level ≥3.7 g/dL (Group 1). The second-best profile comprised treatment with hepatectomy or radiofrequency ablation and serum albumin levels <3.7 g/dL (Group 2). The 5-year overall survival rate was significantly higher in the Group 1 than in the Group 2. Thus, we demonstrated that curative treatment for HCC and serum albumin level >3.7 g/dL was the best prognostic profile for NAFLD-HCC patients. This novel prognostic algorithm for patients with NAFLD-HCC could be used for clinical management. Nature Publishing Group UK 2018-07-11 /pmc/articles/PMC6041283/ /pubmed/29992975 http://dx.doi.org/10.1038/s41598-018-28650-0 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Kawaguchi, Takumi
Tokushige, Katsutoshi
Hyogo, Hideyuki
Aikata, Hiroshi
Nakajima, Tomoaki
Ono, Masafumi
Kawanaka, Miwa
Sawada, Koji
Imajo, Kento
Honda, Koichi
Takahashi, Hirokazu
Mori, Kohjiroh
Tanaka, Saiyu
Seko, Yuya
Nozaki, Yuichi
Kamada, Yoshihiro
Fujii, Hideki
Kawaguchi, Atsushi
Takehara, Tetsuo
Yanase, Mikio
Sumida, Yoshio
Eguchi, Yuichiro
Seike, Masataka
Yoneda, Masato
Suzuki, Yasuaki
Saibara, Toshiji
Karino, Yoshiyasu
Chayama, Kazuaki
Hashimoto, Etsuko
George, Jacob
Torimura, Takuji
A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
title A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
title_full A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
title_fullStr A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
title_full_unstemmed A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
title_short A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
title_sort data mining-based prognostic algorithm for nafld-related hepatoma patients: a nationwide study by the japan study group of nafld
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041283/
https://www.ncbi.nlm.nih.gov/pubmed/29992975
http://dx.doi.org/10.1038/s41598-018-28650-0
work_keys_str_mv AT kawaguchitakumi adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT tokushigekatsutoshi adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT hyogohideyuki adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT aikatahiroshi adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT nakajimatomoaki adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT onomasafumi adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT kawanakamiwa adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT sawadakoji adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT imajokento adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT hondakoichi adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT takahashihirokazu adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT morikohjiroh adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT tanakasaiyu adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT sekoyuya adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT nozakiyuichi adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT kamadayoshihiro adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT fujiihideki adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT kawaguchiatsushi adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT takeharatetsuo adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT yanasemikio adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT sumidayoshio adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT eguchiyuichiro adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT seikemasataka adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT yonedamasato adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT suzukiyasuaki adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT saibaratoshiji adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT karinoyoshiyasu adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT chayamakazuaki adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT hashimotoetsuko adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT georgejacob adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT torimuratakuji adataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT kawaguchitakumi dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT tokushigekatsutoshi dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT hyogohideyuki dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT aikatahiroshi dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT nakajimatomoaki dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT onomasafumi dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT kawanakamiwa dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT sawadakoji dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT imajokento dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT hondakoichi dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT takahashihirokazu dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT morikohjiroh dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT tanakasaiyu dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT sekoyuya dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT nozakiyuichi dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT kamadayoshihiro dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT fujiihideki dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT kawaguchiatsushi dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT takeharatetsuo dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT yanasemikio dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT sumidayoshio dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT eguchiyuichiro dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT seikemasataka dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT yonedamasato dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT suzukiyasuaki dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT saibaratoshiji dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT karinoyoshiyasu dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT chayamakazuaki dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT hashimotoetsuko dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT georgejacob dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld
AT torimuratakuji dataminingbasedprognosticalgorithmfornafldrelatedhepatomapatientsanationwidestudybythejapanstudygroupofnafld